CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

First Page		Document Content
Date: 2016-03-21 02:14:55 Bevacizumab Brain tumor Cancer treatments Glioblastoma multiforme Chemotherapy Reolysin Ranibizumab		CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for Add to Reading List Source URL: www.ctc.usyd.edu.au Download Document from Source Website File Size: 390,10 KB Share Document on Facebook